Five weeks before the biggest event in biotech - how are you getting ready? Why not check out some podcasts on the multitude of topics and issues that will be all the buzz at this year's big show. Start with BIO's very own and brand new BIOtech-Now series, which will highlight a different topic…

The list of more than 300 companies invited to present at the 2008 BIO International Convention’s Business Forum can now be accessed at http://www.bio2008.org/businessforum.  Check it out! Participants in the Business Forum will also have the opportunity to schedule one-on-one partnering meetings…

Here at BIO, we are rethinking our online strategy and we can’t do it without you. Help us provide you with the best online information, tools and resources possible and..... Take our survey!

The Scientist, our trade publication partner for the daily newsletter at the convention, has extended their editorial submission deadline to April 30th. To submit newsworthy content, go to www.the-scientist.com/bio/index/ . Submit something today!  

The final numbers are in and we have good reason to celebrate (perhaps we should get a three-day weekend?!) - there were a record number of institutional investors at the CEO & Investor Conference, 1,050 in total. Most of the more than 200 company presentations were full rooms, since in total…

Despite a delayed train, I got home at 11:30 last night, not too bad considering how bad it could have been! At least the thirty minute delay allowed me to hang out with Mary from Amtrak who repeatedly got requests from folks trying to move up their reservations and she had the pleasure of turning…

Industrial biotech does it all. The Third Wave in biotech is looking bright for the future. Industrial biotech represents the confluence of market demand and the potential for market solution, according to David Berry, MD, PhD of Flagship Ventures - one of the panel speakers. Synthetic…

Validation with big pharma – is it still necessary? Depends on who you talk to. This was one of several questions posed to panelists at today’s business roundtable session. Arguments can be made on both sides, but one thing is for certain, the life sciences financing community has become much more…

The biggest buzz aside from biotech at the CEO conference is definitely the light snowfall outside.  Word on the street is that it will continue to warm up and the snow won't stick, hopefully no one's travel will be dramatically inconvenienced tomorrow. If you want a second opinion: www.weather.com

There's a reason why they call it 'the largest investor conference focused on the biotech industry.' The next few days will bring out the major players in biotech, from investors to venture capitalists to companies with innovations worthy of writing home about. And the Daily Update is your cheat…